Melanoma biomarkers: current status and vision for the future. - Wikidata - wikimedia - TriplyDB

Melanoma biomarkers: current status and vision for the future.

Melanoma biomarkers: current status and vision for the future.

http://www.wikidata.org/entity/Q37357928

about

An evolved ribosome-inactivating protein targets and kills human melanoma cells in vitro and in vivo.Overexpression of Chromatin Assembly Factor-1/p60 helps to predict the prognosis of melanoma patients.Parkinson's disease-related protein, alpha-synuclein, in malignant melanoma Sequential molecular analysis of circulating MCAM/MUC18 expression: a promising disease biomarker related to clinical outcome in melanoma.Rad6 is a Potential Early Marker of Melanoma Development Odontogenic ameloblast-associated protein (ODAM) inhibits growth and migration of human melanoma cells and elicits PTEN elevation and inactivation of PI3K/AKT signaling.TYRP1 mRNA expression in melanoma metastases correlates with clinical outcome Serum CEACAM1 Correlates with Disease Progression and Survival in Malignant Melanoma Patients.Using global gene expression to discriminate thin melanomas with poor outcomes.Arsenic-exposed Keratinocytes Exhibit Differential microRNAs Expression Profile; Potential Implication of miR-21, miR-200a and miR-141 in Melanoma Pathway.Melanoma biomarkers: current status and utility in diagnosis, prognosis, and response to therapy.Predicting and preventing melanoma invasiveness: advances in clarifying E2F1 function.A quantitative proteomic analysis of FFPE melanoma.Melanoma tumors frequently acquire LRP2/megalin expression, which modulates melanoma cell proliferation and survival rates.Minimal residual disease in melanoma: circulating melanoma cells and predictive role of MCAM/MUC18/MelCAM/CD146.Proteinase-activated receptors 1 and 2 regulate invasive behavior of human melanoma cells via activation of protein kinase D1.PAX3d mRNA over 2.76 copies/µL in the bloodstream predicts cutaneous malignant melanoma relapse.

P2860

Q33529309-9AAAEBE9-A897-40EB-9AE2-9004BDD777B5 Q33533679-914702F8-8672-42A8-8B50-A2EB4ABB3054 Q33576922-54A8B4FA-2A76-4FB6-8D69-4C992F29ADB4 Q33935453-C292DFB1-5941-4909-BC5A-2C4C84E49207 Q34092180-89209C8F-2D03-4BB1-8CA1-0781DD49FD44 Q34707834-1138149A-F1C1-4405-A0D4-0B6F394CB425 Q35623342-C16C6334-3A1B-4CC4-8144-CAA2CB9E827D Q35691891-877CA8FA-463C-4E69-86AB-5018886CB473 Q36280622-0B7B0EF8-7DCB-4BC6-9E70-8ED8F4DE5706 Q36762980-BA9CC53D-A94F-4319-AAA9-CD438319D1A0 Q37605787-C8D7CF79-D81B-4A84-ADFF-87A21E8F1A7D Q37809859-41C2DA0C-001D-4262-9199-4121D9248BB0 Q38601442-1F4E64BE-0E34-42F2-8D68-5FC087D2BA13 Q38920389-9ACC392E-65AD-40ED-B1BB-3DE47646B0B3 Q39172101-F3895B3E-9959-4C3D-9C66-0BCCE0079B4B Q39459192-C0E352CF-8C39-4015-907E-856B2FB51E1D Q47120556-0297FE7E-8A86-4BCB-BC26-903819CB01A1

P2860

Melanoma biomarkers: current status and vision for the future.

http://www.wikidata.org/entity/Q37357928

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 December 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Melanoma biomarkers: current status and vision for the future.

@en

Melanoma biomarkers: current status and vision for the future.

@nl

type

label

Melanoma biomarkers: current status and vision for the future.

@en

Melanoma biomarkers: current status and vision for the future.

@nl

prefLabel

Melanoma biomarkers: current status and vision for the future.

@en

Melanoma biomarkers: current status and vision for the future.

@nl

P1433

Q37357928-18C50E12-4726-443D-8B2B-6C3BCBFD729F

P1476

Q37357928-B3E45905-0044-4C67-ABDF-F7327CCFD315

P2093

Q37357928-0B0D1808-2368-4D8A-8392-BD3452E5BC41

P2860

Q37357928-3C138560-EC6F-43AD-8F5D-E56B6075D4C2

Q37357928-42A2BFCA-E641-49E2-9CC4-CD54E43BCA78

Q37357928-5706A205-CCC7-40C7-8FDB-8959401B40DE

Q37357928-B5CC50E5-9BC4-4AC3-B0AC-56237F73EBE6

Q37357928-E174CEA1-0BA5-425B-8642-B4F396BCA541

P304

Q37357928-54D2F1E7-5541-4444-BFFE-F8278DD81EBE

P31

Q37357928-47D82F33-2F2B-40DF-B9AE-06F3FC51D612

P356

Q37357928-3794D77E-E11C-4CF2-AC9A-2E3DD367F7B5

P433

Q37357928-3F640348-59CF-4F12-93E4-F38D298BFF7A

P478

Q37357928-111BD400-9160-47C4-BFFD-9ECCE4A4A346

P50

Q37357928-5EF44DCB-EBF0-44DF-BA02-579D185FF836

Q37357928-9E497FCB-4DCB-48D6-A5B9-754EB2A8F4A6

P577

Q37357928-F964262F-666D-4CD7-BE60-5E81A0113E05

P5875

Q37357928-CA3D1A03-0514-4D1B-9530-254E825EA268

P698

Q37357928-B5EEFFF4-E797-48D8-BAA4-98EA6779FFF7

P921

Q37357928-6F44CD39-C581-4C9A-B5DF-52583289BC57

P356

P1433

Nature Clinical Practice Oncology

P1476

Melanoma biomarkers: current status and vision for the future

@en

P2093

Eliz Konat

http://www.w3.org/2001/XMLSchema#string

P2860

Expression of microtubule-associated protein 2 in benign and malignant melanocytes: implications for differentiation and progression of cutaneous melanoma

Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study.

Microtubule-associated protein 2, a marker of neuronal differentiation, induces mitotic defects, inhibits growth of melanoma cells, and predicts metastatic potential of cutaneous melanoma

Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.

Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and ephrin-A1/EphA2 on melanoma progression.

P304

105-117

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCPONC1296

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Allison R Larson

P577

2008-12-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23688778

http://www.w3.org/2001/XMLSchema#string

P698

19107110

http://www.w3.org/2001/XMLSchema#string

P921